phase readout
saveNCT07528274: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)
view source ↗
comments(0)
5-min edit window · permanent after that